Arch Fam Med
Institution: STANFORD Univ Med Center  | My Account | E-mail Alerts | Access Rights | Sign In
  Vol. 2 No. 7, July 1993 TABLE OF CONTENTS
  •  Online Features
  Clinical Reviews
 This Article
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

Treatment of Mild Hypertension

Decision Before Drugs

Steven C. Zell, MD; Claude K. Lardinois, MD

Arch Fam Med. 1993;2(7):778-786.

Article references have been provided for searching and linking. Additional reference information may be available in the article PDF.

1. National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V). Arch Intern Med. 1993;153:154-183. FREE FULL TEXT
2. US Dept of Health and Human Services. Blood Pressure Levels in Persons 18-74 Years of Age in 1976-1980, and Trends in Blood Pressure From 1960-1980 in the United States. Hyattsville, Md: National Center for Health Statistics; 1986. US Dept of Health and Human Services publication (PHS) 86-1684.
3. Dannenberg AL, Drizd T, Horan MJ, Haynes SG, Leaverton PE. Progress in the battle against hypertension: changes in blood pressure levels in the United States from 1960 to 1980. Hypertension. 1987;10:226-233. FREE FULL TEXT
4. Stamler J, Prineas RJ, Neaton JD, et al. Background and design of the new US trial on diet and drug treatment of 'mild' hypertension (TOMHS). Am J Cardiol. 1987;59:51G-60G. PUBMED
5. The Pooling Project Research Group. Relationship of blood pressure, serum cholesterol, smoking habit, relative weight and ECG abnormalities to incidence of major coronary events: final report of the pooling project. J Chronic Dis. 1978;31:201-306. PUBMED
6. Hypertension Detection and Follow-up Program Cooperative Group. The Hypertension Detection and Follow-up Program: a progress report. Circ Res. 1978;40(suppl):106-109.
7. Mann SJ. Systolic hypertension in the elderly: pathophysiology and management. Arch Intern Med. 1992;152:1977-1984. FREE FULL TEXT
8. Cypress BK. Medication therapy in office visits for hypertension: National Ambulatory Medical Care Survey, 1980. Adv Data. 1982;80:1-11. PUBMED
9. James GD, Pickering TG, Yee LS, Harshfield GA, Riva S, Laragh JH. The reproducibility of average ambulatory, home clinic pressures. Hypertension. 1988;11:545-549. FREE FULL TEXT
10. Report by the Management Committee. The Australian therapeutic trial in mild hypertension. Lancet. 1980;1:1261-1267. PUBMED
11. Pickering TG. Differing perspectives on white coat hypertension. Arch Intern Med. 1992;152:691-692. FREE FULL TEXT
12. Kain HK, Hinman AT, Sokolow M. Arterial blood pressure measurements with a portable recorder in hypertensive patients, I: variability and correlation with 'casual' pressure. Circulation. 1964;30:882-892. FREE FULL TEXT
13. Stamler R, Stamler J, Gosch FC, et al. Primary prevention of hypertension by nutritionalhygienic means: final report of a randomized controlled trial. JAMA. 1989;262:1801-1807. FREE FULL TEXT
14. Stamler R, Stamler J, Grimm R, et al. Nutritional therapy for high blood pressure: final report of a four-year randomized controlled trial— the hypertension control program. JAMA. 1987;257:1484-1491. FREE FULL TEXT
15. Zanchetti A. Treatment goals in hypertension. Am J Med. 1984;76(suppl_2A):1-3. PUBMED
16. Kaplan NM. The appropriate goals of antihypertensive therapy: neither too much nor too little. Ann Intern Med. 1992;116:687-690.
17. Hebert PR, Fiebach NH, Eberlein KA, Taylor JO, Hennekens CH. The community-based randomized trials of pharmacologic treatment of mild to moderate hypertension. Am J Epidemiol. 1988;127:581-590. FREE FULL TEXT
18. Working Group on Management of Patients With Hypertension and High Blood Cholesterol. National Education Program Working Group report on the management of patients with hypertension and high blood cholesterol. Ann Intern Med. 1991;114:224-237. FREE FULL TEXT
19. Littenberg B, Garber AM, Sox HC. Screening for hypertension. Ann Intern Med. 1990;112:192-202. FREE FULL TEXT
20. Mancia G, Bertinieri G, Grassi G, et al. Effects of blood pressure measurement by the doctor on patient's blood pressure and heart rate. Lancet. 1983;2:695-697. PUBMED
21. Freis ED. Rationale against the drug treatment of marginal diastolic systemic hypertension. Am J Cardiol. 1990;66:368-371. PUBMED
22. Pickering TG, James GD, Boddie C, Harshfield GA, Blank S, Laragh JH. How common is white coat hypertension? JAMA. 1988;259:225-228. FREE FULL TEXT
23. Julius S, Ellis CN, Pascual AV, et al. Home blood pressure determination: value in borderline ('labile') hypertension. JAMA. 1974;229:663-666. FREE FULL TEXT
24. National High Blood Pressure Education Program (NHBPEP) Working Group. Report on Ambulatory Blood Pressure Monitoring. Bethesda, Md: US Dept of Health and Human Services; 1990. National Institutes of Health and Prevention publication 90-3028.
25. Rosner B, Polk BF. The implications of blood pressure variability for clinic and screening purposes. J Chronic Dis. 1979;32:451-461. PUBMED
26. Drayer JI, Weber MA, DeYoung JL, Wyle FA. Circadian blood pressure patterns in ambulatory hypertensive patients: effects of age. Am J Med. 1982;73:494-499.
27. Irving JB, Brash HM, Kerr F, Kirby BJ. The value of ambulatory monitoring in borderline and established hypertension. Postgrad Med J. 1976;52(suppl):137-141. PUBMED
28. Pickering TG. The clinical significance of diurnal blood pressure variations: dippers and nondippers. Circulation. 1990;81:700-702. FREE FULL TEXT
29. Verdecchia P, Schillaci G, Procellati C. Dippers versus nondippers. Hypertension. 1991;9(suppl):42-44.
30. O'Brien E, Sheridan J, O'Malley K. Dippers and nondippers. Lancet. 1988;2:397. PUBMED
31. Mejia AD, Egan BM, Schork NJ, Sweifler AJ. Artifacts in measurements of blood pressure and lack of target organ involvement in the assessment of patients with treatment resistant hypertension. Ann Intern Med. 1990;112:270-277. FREE FULL TEXT
32. Osterziel KJ, Julius S, Brant DO. Blood pressure elevation during hindquarter compression in dogs is neurogenic. J Hypertens. 1984;2:411-417. PUBMED
33. Hla KM, Feussner JR. Screening for pseudohypertension: a quantitative, noninvasive approach. Arnch Intern Med. 1988;148:673-676.
34. Hla KM, Vokaty KA, Feussner JR. Overestimation of diastolic blood pressure in the elderly: magnitude of the problem and a potential solution. J Am Geriatr Soc. 1985;33:659-663. PUBMED
35. Hornsby JL, Mongan PF, Taylor AT. Ambulatory blood pressure monitoring in hypertension. Am Fam Physician. 1991;43:1631-1638. PUBMED
36. Health and Public Policy Committee, American College of Physicians. Automated ambulatory blood pressure monitoring. Ann Intern Med. 1986;104:275-278. FREE FULL TEXT
37. Rucker L, Mabourakh S, Onishi R. Treatment decisions in 'white coat' hypertension: do we need the whole 24 hours? South Med J. 1990;83:610-612. PUBMED
38. Pickering TG, Harshfield GA, Devereux RB, Laragh JH. What is the role of ambulatory blood pressure monitoring in the management of hypertensive patients? Hypertension. 1985;7:171-177. FREE FULL TEXT
39. Perloff D, Sokolow M. Cowan R. The prognostic value of ambulatory blood pressure. JAMA. 1983;249:2793-2798.
40. Floras JS, Jones JV, Hassan MO, Osikowska B, Sever PS, Sleight P. Cuff and ambulatory blood pressure in subjects with essential hypertension. Lancet. 1981;2:107-109. PUBMED
41. Devereaux RB. The value of noninvasive measurements in hypertension. JAMA. 1990;264:2798-2799. FREE FULL TEXT
42. Graettinger WF, Weber MA. Left ventricular hypertrophy and antihypertensive therapy. Am Fam Physician. 1992;46:483-489. PUBMED
43. Koren MJ, Devereux RB, Casale PN, Savage DD, Laragh JH. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med. 1991;114:345-352. FREE FULL TEXT
44. de Simone G, Devereux RB, Roman MJ, Schlussel Y, Alderman MH, Laragh JH. Echocardiographic left ventricular mass and electrolyte intake predict arterial hypertension. Ann Intern Med. 1991;114:202-209. FREE FULL TEXT
45. Gottdiener JS, Brown J, Zoltick J, Fletcher RD. Left ventricular hypertrophy in men with normal blood pressure: relation to exaggerated blood pressure response to exercise. Ann Intern Med. 1990;112:161-166. FREE FULL TEXT
46. Schotte DE, Stunkard AJ. The effects of weight reduction on blood pressure in 301 obese patients. Arch Intern Med. 1990;150:1701-1704. FREE FULL TEXT
47. The Trials of Hypertension Prevention Collaborative Research Group. The effects of nonpharmacologic interventions of blood pressure of persons with high normal levels: results of the trials of hypertension prevention, phase I. JAMA. 1992;267:1213-1220. FREE FULL TEXT
48. National High Blood Pressure Education Program Working Group. National High Blood Pressure Education Program Working Group report on primary prevention of hypertension. Arch Intern Med. 1993;153:186-208. FREE FULL TEXT
49. Cutler JA, Follmann D, Elliott P, Suh I. An overview of randomized trials of sodium reduction and blood pressure. Hypertension. 1991;17(suppl 1):27-33.
50. Houston MC. Examining dietary sodium as cause and therapy. Consultant. 1985;25:235-236, 240-245.
51. Elliott P, Dyer A, Stamler R. The INTERSALT study: results for 24 hour sodium and potassium by age and sex. J Hum Hypertens. 1989;3:323-330. PUBMED
52. Krishna GG, Kapoor SC. Potassium depletion exacerbates essential hypertension. Ann Intern Med. 1991;115:77-83. FREE FULL TEXT
53. Siani A, Strazzullo P, Giacco A, Pacioni D, Celentano E, Mancini M. Increasing the dietary potassium intake reduces the need for antihypertensive medication. Ann Intern Med. 1991;115:753-759. FREE FULL TEXT
54. Ophir O, Peer G, Gilad J, Blum M, Aviram A. Low blood pressure in vegetarians: the possible role of potassium. Am J Clin Nutr. 1983;37:755-762. FREE FULL TEXT
55. McCarron DA, Morris CD, Cole C. Dietary calcium in human hypertension. Science. 1982;217:267-269. FREE FULL TEXT
56. Flatman PW, Lew VL. The magnesium dependence of sodium-pump-mediated sodiumpotassium and sodium-sodium exchange in intact human red cell. J Physiol. 1981;315:421-446. FREE FULL TEXT
57. Motoyama T, Sano H, Fukuzaki H. Oral magnesium supplementation in patients with essential hypertension. Hypertension. 1989;13:227-232. FREE FULL TEXT
58. Potter JF, Beevers DG. Pressor effect of alcohol in hypertension. Lancet. 1984;1:119-122. PUBMED
59. Tuomilehto J, Enlund H, Salonen JT, Nissenen A. Alcohol patient compliance and blood pressure control in hypertensive patients. Scand J Soc Med. 1984;12:177-181. PUBMED
60. Saunders JB, Beevers DG, Paton A. Alcohol induced hypertension. Lancet. 1981;2:653-656. PUBMED
61. Anderson DE. Interaction of stress, salt, and blood pressure. Annu Rev Physiol. 1984;46:143-153. PUBMED
62. Patel C, Marmot MG, Terry DJ. Controlled trial of biofeedback-aided behavioural methods in reducing mild hypertension. BMJ Clin Res Ed. 1981;282:2005-2008. FREE FULL TEXT
63. Robertson D, Wade D, Workman R, Woosley RL, Oates JA. Tolerance to the humoral and hemodynamic effects of caffeine in man. J Clin Invest. 1981;67:1111-1117. PUBMED
64. Gordon T, Kannel WB, Dawber TR, McGee D. Changes associated with quitting cigarette smoking: the Framingham Study. Am Heart J. 1975;90:332-338.
65. Houston MC. Nonsteroidal anti-inflammatory drugs and antihypertensives. Am J Med. 1991;90(suppl 5A):42-47.
66. Brown J, Dollery C, Valdes G. Interaction of nonsteroidal anti-inflammatory drugs with antihypertensive and diuretic agents: control of vascular reactivity by endogenous prostanoids. Am J Med. 1986;81:(suppl 2B):43-57. PUBMED
67. Wong DG, Lamki L, Spence JD, Freeman D, McDonald JWD. Effect of nonsteroidal antiinflammatory drugs on control of hypertension by beta blockers and diuretics. Lancet. 1986;1:997-1001. PUBMED
68. Koopmans PP, Thien TH, Gribnau FWJ. Influence of nonsteroidal anti-inflammatory drugs on diuretic treatment of mild to moderate essential hypertension. BMJ. 1984;289:1492-1494. FREE FULL TEXT
69. Schmieder RE, Rockstroh JK, Messerli FH. Antihypertensive therapy: to stop or not to stop? JAMA. 1991;265:1566-1571. FREE FULL TEXT
70. Beckenridge A. Compliance of hypertensive patients with pharmacologic treatment. Hypertension. 1983;5(suppl III):85-89.
71. Hollifield JW. Potassium and magnesium abnormalities: diuretics and arrhythmias in hypertension. Am J Med. 1984;77(suppl 5A):28-32. PUBMED
72. Grimm RH Jr, Leon AS, Hunninghake DB, Lenz K, Hannan P, Blackburn H. Effects of thiazide diuretics on plasma lipids and lipoproteins in mildly hypertensive patients: a double-blind controlled trial. Ann Intern Med. 1981;94:7-11. FREE FULL TEXT
73. Veterans Administration Cooperative Study Group on Antihypertensive Agents. Return of elevated blood pressure after withdrawal of antihypertensive drugs. Circulation. 1975;51:1107-1113. FREE FULL TEXT
74. Alderman MH, Davis TK, Gerber LM, Robb M. Antihypertensive drug therapy withdrawal in a general population. Arch Intern Med. 1986;146:1309-1311. FREE FULL TEXT
75. Maland LJ, Lutz LJ, Castle CH. Effects of withdrawing diuretic therapy on blood pressure in mild hypertension. Hypertension. 1983;5:539-544. FREE FULL TEXT
76. Finnerty FA. Step-down treatment of mild systemic hypertension. Am J Cardiol. 1984;53:1304-1307. PUBMED
77. Medical Research Council Working Party on Mild Hypertension. Course of blood pressure in mild hypertensives after withdrawal of long-term antihypertensive treatment. BMJ. 1986;293:988-992. FREE FULL TEXT
78. Levinson PD, Khatri IM, Freis ED. Persistence of normal blood pressure after withdrawal of drug treatment in mild hypertension. Arch Intern Med. 1982;142:2265-2268. PUBMED
79. Freis ED, Thomas JR, Fisher SG, et al. Effects of reduction in drugs or dosage after longterm control of systemic hypertension. Am J Cardiol. 1989;63:702-708. PUBMED
80. Page IH, Dustan HP. Persistence of normal blood pressure after discontinuing treatment in hypertensive patients. Circulation. 1962;25:433-436. FREE FULL TEXT
81. Thurm RH, Smith WM. On resetting of 'barostats' in hypertensive patients. JAMA. 1967;201:301-304. FREE FULL TEXT
82. Jennings GL, Korner PI, Laufer E, Ester MD, Burton D, Bruce A. How hypertension redevelops after cessation of longterm therapy. J Hypertens. 1984;2(suppl):217-219.
83. Schmieder RE, Ruddel H, Neus H, Neus J, Von Eiff AW. Predictors of blood pressure increases after withdrawal of antihypertensive therapy. J Hypertens. 1985;3(suppl):457-459. PUBMED
84. Wassertheil-Smoller S, Blaufox D, Oberman AS, Langford HG, Davis BR, Wylie-Rosett J. The trial of antihypertensive interventions and management (TAIM) study: adequate weight loss, alone and combined with drug therapy in the treatment of mild hypertension. Arch Intern Med. 1992;152:131-136. FREE FULL TEXT
85. Bostwick RM, Luepker RV, Kofron PM, Pirie PL. Changes in physician practice for the prevention of cardiovascular disease. Arch Intern Med. 1991;151:478-484. FREE FULL TEXT
86. Grimm RH, Luepker RV, Blackburn H. Cardiovascular disease prevention: attitudes and practice habits in community physicians. Circulation. 1983;68(suppl):160. Abstract.
87. Fortmann SP, Sallis JF, Magnus PM, Farquhar JW. Attitudes and practices of physicians regarding hypertension and smoking: the Stanford five city project. Prev Med. 1985;14:70-80. PUBMED
88. Breckenridge MB, Kostis JB. Isolated systolic hypertension in the elderly: results of a statewide survey of clinical practice in New Jersey. Am J Med. 1985;86:370-375.
89. Metropolitan Life Insurance Company. Blood Pressure, Insurance Experience and Its Implications. New York, NY: Metropolitan Life Insurance Co; 1961.
90. Anderson T. Reexamination of some of the Framingham Study blood pressure data. Lancet. 1978;2:1139-1141. PUBMED
91. McGee D, Gordon T. The results of the Framingham Study applied to four other US-based epidemiological studies of cardiovascular disease. In: Kannel WB, Gordon T, eds. The Framingham Study: An Epidemiological Investigation of Cardiovascular Disease. Washington, DC: US Dept of Health, Education, and Welfare; 1976; Section 31. National Institutes of Health publication 76-1083.
92. Fletcher AE, Bulpitt CJ. How far should blood pressure be lowered? N Engl J Med. 1992;326:251-254. PUBMED
93. The IPPPSH Collaborative Group. Cardiovascular risk and risk factors in a randomized trial of treatment based on the beta blocker oxprenolol: the international prospective primary prevention study in hypertension (IPPPSH). J Hypertens. 1985;3:379-392. PUBMED
94. Fletcher A, Beevers DG, Bulpitt CJ, et al. The relationship between a low treated blood pressure and IHD mortality: a report from the DHSS hypertension care computing project (DHCCP). J Hum Hypertens. 1988;2:11-15. PUBMED
95. Waller PC, Isles CG, Lever AF, Murray GD, McInnes GT. Does therapeutic reduction of blood pressure cause death from coronary heart disease? J Hum Hypertens. 1988;2:7-10. PUBMED
96. Miall WE, Greenberg G. Mild Hypertension: Is There Pressure to Treat? Cambridge, England: Cambridge University Press; 1987.
97. 1989 Guidelines for the Management of Mild Hypertension: Memorandum From A WHO/ISH Meeting. J Hypertens. 1989;7:689-693. PUBMED
98. Farnett L, Mulrow CD, Linn WD, Lucey CR, Tuley MR. The J-curve phenomenon and the treatment of hypertension: is there a point beyond which pressure reduction is dangerous? JAMA. 1991;265:489-495. FREE FULL TEXT
99. Cruickshank JM, Thorp JM, Zacharias FJ. Benefits and potential harm of lowering blood pressure. Lancet. 1985;2:581-583. PUBMED
100. Samuelsson O, Wilhelmsen L, Andersson OK, Pennert K, Berglund G. Cardiovascular morbidity in relation to change in blood pressure and serum cholesterol levels in treated hypertension: results from the primary prevention trial in Göteborg, Sweden. JAMA. 1987;258:1768-1776. FREE FULL TEXT
101. Cruickshank JM. Coronary flow reserve and the J-curve relation between diastolic blood pressure and myocardial infarction. BMJ. 1988;297:1227-1230. FREE FULL TEXT
102. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the systolic hypertension in the elderly program (SHEP). JAMA. 1991;265:3255-3264. FREE FULL TEXT
103. Hostetter TH, Rennke HG, Brenner BM. The case for intrarenal hypertension in the initiation and progression of diabetic and other glomerulopathies. Am J Med. 1982;72:375-380. PUBMED
104. Drury PL. Diabetes and arterial hypertension. Diabetologia. 1983;24:1-9. PUBMED
105. The Working Group on Hypertension in Diabetes. Statement on hypertension in diabetes mellitus. Arch Intern Med. 1987;147:830-842. FREE FULL TEXT
106. Morgensen CE, Hansen KW, Pedersen MM, Christensen CK. Renal factors influencing blood pressure threshold and choice of treatment for hypertension in IDDM. Diabetes Care. 1991;14(suppl 4):13-26. PUBMED
107. Christlieb AR. Treatment selection considerations for the hypertensive diabetic patient. Arch Intern Med. 1990;150:1167-1174. FREE FULL TEXT
108. Bakris GL. Effects of diltiazem or lisinopril on massive proteinuria associated with diabetes mellitus. Ann Intern Med. 1990;112:707-708. FREE FULL TEXT
109. Feldman AM. Can we alter survival in patients with congestive heart failure? JAMA. 1992;267:1956-1961. FREE FULL TEXT
110. The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med. 1987;316:1429-1435. ABSTRACT
111. Cohn JN, Archibald D, Johnson G, the VA Cooperative Study Group. Effects of vasodilator therapy on peak exercise oxygen consumption in heart failure: V-HeFT. Circulation. 1987;76(suppl IV):IV-443. Abstract.
112. The SOLVD Investigators. Studies of left ventricular dysfunction (SOLVD): rationale, design, and methods—two trials that evaluate the effect of enalapril in patients with reduced ejection fraction. Am J Cardiol. 1990;66:315-322. PUBMED
113. Cohn JN, Johnson G, Ziesche S, et al. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med. 1991;325:303-310. ABSTRACT
114. Kannel WB, Gordon T, Offutt D. Left ventricular hypertrophy by electrocardiogram: prevalence, incidence, and mortality in the Framingham Study. Ann Intern Med. 1969;71:89-105. FREE FULL TEXT
115. Rowlands DB, Ireland MA, Stallard TJ. Assessment of left ventricular mass and its response to antihypertensive treatment. Lancet. 1982;1:467-470. PUBMED
116. Hill L, Monaghan M, Richardson PJ. Regression of left ventricular hypertrophy during treatment with antihypertensive agents. Br J Clin Pharmacol. 1979;7(suppl):255-260.
117. Schlant RC, Feiner JM, Blummerstein A, et al. Echocardiographic studies of left ventricular anatomy and function before and after treatment of essential hypertension. Am J Cardiol. 1977;39:296. Abstract.